Difficulty: Medium
Average Score: 88%
Practice
A 33-year-old patient with asthma is being treated with nedocromil. Which of the following is the major action of nedocromil?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Block of mediator release from mast cells. Nedocromil is a mast cell stabilizer that works by preventing the release of inflammatory mediators such as histamine, leukotrienes, and prostaglandins from mast cells. This action helps to reduce bronchoconstriction, mucus secretion, and airway inflammation in asthma.
Option A, blocking of calcium channels in lymphocytes, is incorrect as nedocromil does not act on calcium channels in lymphocytes. Option C, smooth muscle relaxation in the bronchi, is also incorrect as nedocromil does not directly cause bronchodilation but rather works by preventing inflammatory responses. Option D, stimulation of cortisol release by the adrenals, is unrelated to the mechanism of action of nedocromil in treating asthma.
In an educational context, understanding the mechanism of action of respiratory drugs like nedocromil is crucial for healthcare professionals to make informed decisions about treatment options for patients with respiratory conditions. It also highlights the importance of knowing how different classes of medications work to achieve therapeutic outcomes in managing asthma and other respiratory diseases effectively.
Option A, blocking of calcium channels in lymphocytes, is incorrect as nedocromil does not act on calcium channels in lymphocytes. Option C, smooth muscle relaxation in the bronchi, is also incorrect as nedocromil does not directly cause bronchodilation but rather works by preventing inflammatory responses. Option D, stimulation of cortisol release by the adrenals, is unrelated to the mechanism of action of nedocromil in treating asthma.
In an educational context, understanding the mechanism of action of respiratory drugs like nedocromil is crucial for healthcare professionals to make informed decisions about treatment options for patients with respiratory conditions. It also highlights the importance of knowing how different classes of medications work to achieve therapeutic outcomes in managing asthma and other respiratory diseases effectively.